Related Experiment Video
Updated: Jun 5, 2025
Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
Voltage Gated Calcium Channel Dysregulation May Contribute to Neurological Symptoms in Calmodulinopathies
Abstract:
Calmodulinopathies are caused by mutations in calmodulin (CaM), and result in debilitating cardiac arrythmias such as long-QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). In addition, many patients exhibit neurological comorbidities, including developmental delay and autism spectrum disorder. Until now, most work into these mutations has focused on cardiac effects, identifying impairment of Ca 2+ /CaM-dependent inactivation (CDI) of Ca V 1.2 channels as a major pathogenic mechanism. However, the impact of these mutations on neurological function has yet to be fully explored. CaM regulation of voltage-gated calcium channels (VGCCs) is a critical element of neuronal function, implicating multiple VGCC subtypes in the neurological pathogenesis of calmodulinopathies. Here, we explore the potential for pathological CaM variants to impair the Ca 2+ /CaM-dependent regulation of Ca V 1.3 and Ca V 2.1, both essential for neuronal function. We find that mutations in CaM can impair the CDI of Ca V 1.3 and reduce the Ca 2+ -dependent facilitation (CDF) of Ca V 2.1 channels. We find that mutations associated with significant neurological symptoms exhibit marked effects on Ca V 1.3 CDI, with overlapping but distinct impacts on Ca V 2.1 CDF. Moreover, while the majority of CaM variants demonstrated the ability to bind the IQ region of each channel, distinct differences were noted between Ca V 1.3 and Ca V 2.1, demonstrating distinct CaM interactions across the two channel subtypes. Further, C-domain CaM variants display a reduced ability to sense Ca 2+ when in complex with the Ca V IQ domains, explaining the Ca 2+ /CaM regulation deficits. Overall, these results support the possibility that disrupted Ca 2+ /CaM regulation of VGCCs may contribute to neurological pathogenesis of calmodulinopathies.
Insights
Mutations in calmodulin (CaM) disrupt calcium channel regulation, potentially explaining neurological issues in calmodulinopathies. This study investigates CaM
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Calmodulinopathies, caused by calmodulin (CaM) mutations, lead to cardiac arrhythmias and neurological comorbidities like developmental delay and autism spectrum disorder.
- Previous research focused on cardiac effects, particularly impaired Ca 2+ /CaM-dependent inactivation (CDI) of Ca V 1.2 channels.
- The neurological impact of CaM mutations and their effect on neuronal voltage-gated calcium channels (VGCCs) remain underexplored.
Purpose of the Study:
- To investigate how pathological CaM variants affect the Ca 2+ /CaM-dependent regulation of Ca V 1.3 and Ca V 2.1 channels, crucial for neuronal function.
- To determine if CaM mutations impair Ca V 1.3 CDI and Ca V 2.1 Ca 2+ -dependent facilitation (CDF).
- To analyze the distinct CaM interactions with Ca V 1.3 and Ca V 2.1 channels and the role of Ca 2+ sensing.
Main Methods:
- Electrophysiological analysis of Ca V 1.3 and Ca V 2.1 channel function in the presence of wild-type and mutant CaM.
- Assessment of Ca 2+ /CaM-dependent inactivation (CDI) for Ca V 1.3 and Ca 2+ -dependent facilitation (CDF) for Ca V 2.1.
- Investigation of CaM binding to the IQ regions of Ca V 1.3 and Ca V 2.1, and evaluation of Ca 2+ sensing by C-domain CaM variants.
Main Results:
- CaM mutations were found to impair Ca V 1.3 CDI and reduce Ca V 2.1 CDF.
- Mutations linked to neurological symptoms showed significant effects on Ca V 1.3 CDI and distinct impacts on Ca V 2.1 CDF.
- Distinct CaM interactions with Ca V 1.3 and Ca V 2.1 were observed, with C-domain CaM variants showing reduced Ca 2+ sensing.
Conclusions:
- Disrupted Ca 2+ /CaM regulation of VGCCs, specifically Ca V 1.3 and Ca V 2.1, may contribute to the neurological pathogenesis of calmodulinopathies.
- The findings highlight the differential impact of CaM mutations on various VGCC subtypes, suggesting subtype-specific mechanisms in disease.
- Understanding these molecular mechanisms provides a basis for exploring therapeutic strategies targeting neurological aspects of calmodulinopathies.
More Related Videos
Related Concept Videos
01:16Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
01:26Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
01:27Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
01:19The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
01:12Mechanically-gated Ion Channels